Medical
Health
Therapy

Portola Pharmaceuticals

$25.89
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.21 (0.82%) Today
$0.00 (0.00%) As of 4:08 PM EDT after-hours

Why Robinhood?

You can buy or sell PTLA and other stocks, options, ETFs, and crypto commission-free!

About PTLA

Portola Pharmaceuticals, Inc. engages in the development and commercialization of novel therapeutics in the areas of thrombosis, other hematologic disorders and inflammation. It offers Andexxa, and Bevyxxa medicines. Read More The company was founded by Charles J. Homcy and David R. Philips on September 2, 2003 and is headquartered in South San Francisco, CA.

Employees
324
Headquarters
South San Francisco, California
Founded
2003
Market Cap
1.75B
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
704.90K
High Today
$26.14
Low Today
$25.26
Open Price
$25.66
Volume
682.46K
52 Week High
$42.17
52 Week Low
$14.81

Collections

Medical
Health
Therapy
Technology
Pharmaceutical
2013 IPO

PTLA Earnings

-$1.62
-$1.42
-$1.22
-$1.02
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 8, Pre-Market

Popular Stocks

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.